Combining non-pharmacological treatments with pharmacotherapies for neurological disorders: A unique interface of the brain, drug-device, and intellectual property

Frontiers in Neurology

Volumn 5 JUL, Issue , 2014, Pages

  Bulaj, Grzegorz ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Chronic disease; Depression; Dopamine; Epilepsy; Fatigue; Mozart; Psychiatric disorders

Indexed keywords

ARTICLE; BRAIN COMPUTER INTERFACE; BRAIN FUNCTION; COGNITIVE THERAPY; COMORBIDITY; COMPUTER PROGRAM; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; EPILEPSY; FUNCTIONAL ASSESSMENT; GAME; HUMAN; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; MOBILE APPLICATION; MUSIC THERAPY; NEUROLOGIC DISEASE; NONHUMAN; OUTCOME ASSESSMENT; PROCESS DEVELOPMENT; PSYCHOPHARMACOTHERAPY; RECREATION; SOCIAL ATTITUDE; SOCIAL INTERACTION;

EID: 84904388137     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2014.00126     Document Type: Article

References (111)

1. Charani E, Castro-Sanchez E, Moore LS, Holmes A. Do smartphone applications in healthcare require a governance and legal framework? It depends on the application! BMC Med (2014) 12:29. doi: 10.1186/1741-7015-12-29
2. Food and Drug Administration. Mobile Medical Applications: Guidance for Industry and Food and Drug Administration Staff (2013). Available from: http://www.fda.gov/downloads/MedicalDevices/./UCM263366.pdf
3. De Jongh T, Gurol-Urganci I, Vodopivec-Jamsek V, Car J, Atun R. Mobile phone messaging for facilitating self-management of long-term illnesses. Cochrane Database Syst Rev (2013) 12:CD007459. doi:10.1002/14651858.CD007459.pub2
4. Jones KR, Lekhak N, Kaewluang N. Using mobile phones and short message service to deliver self-management interventions for chronic conditions: a meta-review. Worldviews Evid Based Nurs (2014) 11:81-8. doi:10.1111/wvn.12030
5. Hayes DF, Markus HS, Leslie RD, Topol EJ. Personalized medicine: risk prediction, targeted therapies and mobile health technology. BMC Med (2014) 12:37. doi:10.1186/1741-7015-12-37
6. Finitsis DJ, Pellowski JA, Johnson BT. Text message intervention designs to promote adherence to antiretroviral therapy (ART): a meta-analysis of randomized controlled trials. PLoS One (2014) 9:e88166. doi:10.1371/journal.pone.0088166
7. Free C, Phillips G, Galli L, Watson L, Felix L, Edwards P, et al. The effectiveness of mobile-health technology-based health behaviour change or disease management interventions for health care consumers: a systematic review. PLoS Med (2013) 10:e1001362. doi:10.1371/journal.pmed.1001362
8. Aikens JE, Zivin K, Trivedi R, Piette JD. Diabetes self-management support using mHealth and enhanced informal caregiving. J Diabetes Complications (2014) 28:171-6. doi:10.1016/j.jdiacomp.2013.11.008
9. Dayer L, Heldenbrand S, Anderson P, Gubbins PO, Martin BC. Smartphone medication adherence apps: potential benefits to patients and providers. J Am Pharm Assoc (2003) 53:172-81. doi:10.1331/JAPhA.2013.12202
10. Vervloet M, van Dijk L, Santen-Reestman J, van Vlijmen B, van Wingerden P, Bouvy ML, et al. SMS reminders improve adherence to oral medication in type 2 diabetes patients who are real time electronically monitored. Int J Med Inform (2012) 81:594-604. doi:10.1016/j.ijmedinf.2012.05.005
11. Reynoldson C, Stones C, Allsop M, Gardner P, Bennett MI, Closs SJ, et al. Assessing the quality and usability of smartphone apps for pain self-management. Pain Med (2014) 15(6):898-909. doi:10.1111/pme.12327
12. Wallace LS, Dhingra LK. A systematic review of smartphone applications for chronic pain available for download in the United States. J Opioid Manag (2014) 10:63-8. doi:10.5055/jom.2014.0193
13. Marcano Belisario JS, Huckvale K, Greenfield G, Car J, Gunn LH. Smartphone and tablet self management apps for asthma. Cochrane Database Syst Rev (2013) 11:CD010013. doi:10.1002/14651858.CD010013.pub2
14. Andrews G, Cuijpers P, Craske MG, McEvoy P, Titov N. Computer therapy for the anxiety and depressive disorders is effective, acceptable and practical health care: a meta-analysis. PLoS One (2010) 5:e13196. doi:10.1371/journal.pone.0013196
15. Donker T, Petrie K, Proudfoot J, Clarke J, Birch MR, Christensen H. Smartphones for smarter delivery of mental health programs: a systematic review. J Med Internet Res (2013) 15:e247. doi:10.2196/jmir.2791
16. Quinn CC, Clough SS, Minor JM, Lender D, Okafor MC, Gruber-Baldini A. WellDoc mobile diabetes management randomized controlled trial: change in clinical and behavioral outcomes and patient and physician satisfaction. Diabetes Technol Ther (2008) 10:160-8. doi:10.1089/dia.2008.0283
17. Quinn CC, Gruber-Baldini AL, Shardell M, Weed K, Clough SS, Peeples M, et al. Mobile diabetes intervention study: testing a personalized treatment/behavioral communication intervention for blood glucose control. Contemp Clin Trials (2009) 30:334-46. doi:10.1016/j.cct.2009.02.004
18. Quinn CC, Shardell MD, Terrin ML, Barr EA, Ballew SH, Gruber-Baldini AL. Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control. Diabetes Care (2011) 34:1934-42. doi:10.2337/dc11-0366
19. Shuren J. The FDA's role in the development of medical mobile applications. Clin Pharmacol Ther (2014) 95:485-8. doi:10.1038/clpt.2014.45
20. Hieftje K, Edelman EJ, Camenga DR, Fiellin LE. Electronic media-based health interventions promoting behavior change in youth: a systematic review. JAMA Pediatr (2013) 167:574-80. doi:10.1001/jamapediatrics.2013.1095
21. Baranowski T, Buday R, Thompson D, Lyons EJ, Lu AS, Baranowski J. Developing games for health behavior change: getting started. Games Health J (2013) 2:183-90. doi:10.1089/g4h.2013.0048
22. Bruggers CS, Altizer RA, Kessler RR, Caldwell CB, Coppersmith K, Warner L, et al. Patient-empowerment interactive technologies. Sci Transl Med (2012) 4:152-116. doi:10.1126/scitranslmed.3004009
23. Lieberman DA. Video games for diabetes self-management: examples and design strategies. J Diabetes Sci Technol (2012) 6:802-6. doi:10.1177/193229681200600410
24. Esculier JF, Vaudrin J, Beriault P, Gagnon K, Tremblay LE. Home-based balance training programme using Wii fit with balance board for Parkinsons's disease: a pilot study. J Rehabil Med (2012) 44:144-50. doi:10.2340/16501977-0922
25. Russoniello CV, Fish M, O'Brien K. The efficacy of casual videogame play in reducing clinical depression: a randomized controlled study. Games Health J (2013) 2:341-6. doi:10.1089/g4h.2013.0010
26. Kottink AIR, Prange GB, Krabben T, Rietman JS, Buurke JH. Gaming and conventional exercise for improvement of arm function after stroke: a randomized controlled pilot study. Games Health J (2014) 3:184-91. doi:10.1089/g4h.2014.0026
27. Beale IL, Kato PM, Marin-Bowling VM, Guthrie N, Cole SW. Improvement in cancer-related knowledge following use of a psychoeducational video game for adolescents and young adults with cancer. J Adolesc Health (2007) 41:263-70. doi:10.1016/j.jadohealth.2007.04.006
28. Kato PM, Cole SW, Bradlyn AS, Pollock BH. A video game improves behavioral outcomes in adolescents and young adults with cancer: a randomized trial. Pediatrics (2008) 122:e305-17. doi:10.1542/peds.2007-3134
29. Merry SN, Stasiak K, Shepherd M, Frampton C, Fleming T, Lucassen MF. The effectiveness of SPARX, a computerised self help intervention for adolescents seeking help for depression: randomised controlled non-inferiority trial. BMJ (2012) 344:e2598. doi:10.1136/bmj.e2598
30. Anguera JA, Boccanfuso J, Rintoul JL, Al-Hashimi O, Faraji F, Janowich J, et al. Video game training enhances cognitive control in older adults. Nature (2013) 501:97-101. doi:10.1038/nature12486
31. Hieftje K, Rosenthal MS, Camenga DR, Edelman EJ, Fiellin LE. A qualitative study to inform the development of a video game for adolescent HIV prevention. Games Health J (2012) 1:294-8. doi:10.1089/g4h.2012.0025
32. Simons M, Chinapaw MJ, van de Bovenkamp M, de Boer MR, Seidell JC, Brug J, et al. Active video games as a tool to prevent excessive weight gain in adolescents: rationale, design and methods of a randomized controlled trial. BMC Public Health (2014) 14:275. doi:10.1186/1471-2458-14-275
33. Koelsch S. Brain correlates of music-evoked emotions. Nat Rev Neurosci (2014) 15:170-80. doi:10.1038/nrn3666
34. Chanda ML, Levitin DJ. The neurochemistry of music. Trends Cogn Sci (2013) 17(4):179-93. doi:10.1016/j.tics.2013.02.007
35. Fancourt D, Ockelford A, Belai A. The psychoneuroimmunological effects of music: a systematic review and a new model. Brain Behav Immun (2014) 36:15-26. doi:10.1016/j.bbi.2013.10.014
36. Dastgheib SS, Layegh P, Sadeghi R, Foroughipur M, Shoeibi A, Gorji A. The effects of Mozart's music on interictal activity in epileptic patients: systematic review and meta-analysis of the literature. Curr Neurol Neurosci Rep (2014) 14:420. doi:10.1007/s11910-013-0420-x
37. Lin L, Yang R. Using music to treat epilepsy in children: a review. Music Med (2013) 5:242-7. doi:10.1177/1943862113500506
38. Hughes JR, Daaboul Y, Fino JJ, Shaw GL. The "Mozart effect" on epileptiform activity. Clin Electroencephalogr (1998) 29:109-19. doi:10.1177/155005949802900301
39. Lin LC, Lee WT, Wu HC, Tsai CL, Wei RC, Jong YJ, et al. Mozart K.448 and epileptiform discharges: effect of ratio of lower to higher harmonics. Epilepsy Res (2010) 89:238-45. doi:10.1016/j.eplepsyres.2010.01.007
40. Lin LC, Lee WT, Wu HC, Tsai CL, Wei RC, Mok HK, et al. The long-term effect of listening to Mozart K.448 decreases epileptiform discharges in children with epilepsy. Epilepsy Behav (2011) 21:420-4. doi:10.1016/j.yebeh.2011.05.015
41. Lin LC, Lee MW, Wei RC, Mok HK, Wu HC, Tsai CL, et al. Mozart k.545 mimics Mozart k.448 in reducing epileptiform discharges in epileptic children. Evid Based Complement Alternat Med (2012) 2012:607517. doi:10.1155/2012/607517
42. Lin LC, Chiang CT, Lee MW, Mok HK, Yang YH, Wu HC, et al. Parasympathetic activation is involved in reducing epileptiform discharges when listening to Mozart music. Clin Neurophysiol (2013) 124:1528-35. doi:10.1016/j.clinph.2013.02.021
43. Lin LC, Lee MW, Wei RC, Mok HK, Yang RC. Mozart K.448 listening decreased seizure recurrence and epileptiform discharges in children with first unprovoked seizures: a randomized controlled study. BMC Complement Altern Med (2014) 14:17. doi:10.1186/1472-6882-14-17
44. Bodner M, Turner RP, Schwacke J, Bowers C, Norment C. Reduction of seizure occurrence from exposure to auditory stimulation in individuals with neurological handicaps: a randomized controlled trial. PLoS One (2012) 7:e45303. doi:10.1371/journal.pone.0045303
45. Bernatzky G, Presch M, Anderson M, Panksepp J. Emotional foundations of music as a non-pharmacological pain management tool in modern medicine. Neurosci Biobehav Rev (2011) 35:1989-99. doi:10.1016/j.neubiorev.2011.06.005
46. Cole LC, Lobiondo-Wood G. Music as an adjuvant therapy in control of pain and symptoms in hospitalized adults: a systematic review. Pain Manag Nurs (2014) 15:406-25. doi:10.1016/j.pmn.2012.08.010
47. Guetin S, Ginies P, Siou DK, Picot MC, Pommie C, Guldner E, et al. The effects of music intervention in the management of chronic pain: a single-blind, randomized, controlled trial. Clin J Pain (2012) 28:329-37. doi:10.1097/AJP.0b013e31822be973
48. Garza-Villarreal EA, Wilson AD, Vase L, Brattico E, Barrios FA, Jensen TS, et al. Music reduces pain and increases functional mobility in fibromyalgia. Front Psychol (2014) 5:90. doi:10.3389/fpsyg.2014.00090
49. Rodriguez-Fornells A, Rojo N, Amengual JL, Ripolles P, Altenmuller E, Munte TF. The involvement of audio-motor coupling in the music-supported therapy applied to stroke patients. Ann N Y Acad Sci (2012) 1252:282-93. doi:10.1111/j.1749-6632.2011.06425.x
50. Altenmuller E, Schlaug G. Neurobiological aspects of neurologic music therapy. Music Med (2013) 5:210-6. doi:10.1177/1943862113505328
51. Ueda T, Suzukamo Y, Sato M, Izumi S. Effects of music therapy on behavioral and psychological symptoms of dementia: a systematic review and meta-analysis. Ageing Res Rev (2013) 12:628-41. doi:10.1016/j.arr.2013.02.003
52. Vasionyte I, Madison G. Musical intervention for patients with dementia: a meta-analysis. J Clin Nurs (2013) 22:1203-16. doi:10.1111/jocn.12166
53. Erkkila J, Punkanen M, Fachner J, Ala-Ruona E, Pontio I, Tervaniemi M, et al. Individual music therapy for depression: randomised controlled trial. Br J Psychiatry (2011) 199:132-9. doi:10.1192/bjp.bp.110.085431
54. Bradt J, Dileo C, Shim M. Music interventions for preoperative anxiety. Cochrane Database Syst Rev (2013) 6:CD006908. doi:10.1002/14651858.CD006908.pub2
55. Chlan LL, Weinert CR, Heiderscheit A, Tracy MF, Skaar DJ, Guttormson JL, et al. Effects of patient-directed music intervention on anxiety and sedative exposure in critically ill patients receiving mechanical ventilatory support: a randomized clinical trial. JAMA (2013) 309:2335-44. doi:10.1001/jama.2013.5670
56. Robb SL, Burns DS, Stegenga KA, Haut PR, Monahan PO, Meza J, et al. Randomized clinical trial of therapeutic music video intervention for resilience outcomes in adolescents/young adults undergoing hematopoietic stem cell transplant: a report from the children's oncology group. Cancer (2014) 120:909-17. doi:10.1002/cncr.28355
57. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med (2005) 353:487-97. doi:10.1056/NEJMra050100
58. Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc (2011) 86:304-14. doi:10.4065/mcp.2010.0575
59. World Health Organization. Adherence to Long Term Therapies: Evidence for Action. Geneva: World Health Organization (2003).
60. Forissier T, Firlik K. Estimated Annual Pharmaceutical Revenue Loss Due to Medication Non-Adherence. Paris: Capgemini Consulting (2012). p. 1-20.
61. Landwehr B. Big games: one company's experience with gamification of health. Games Health J (2014) 3:64-6. doi:10.1089/g4h.2014.0007
62. Bradshaw DH, Chapman CR, Jacobson RC, Donaldson GW. Effects of music engagement on responses to painful stimulation. Clin J Pain (2012) 28:418-27. doi:10.1097/AJP.0b013e318236c8ca
63. Bradshaw DH, Donaldson GW, Jacobson RC, Nakamura Y, Chapman CR. Individual differences in the effects of music engagement on responses to painful stimulation. J Pain (2011) 12:1262-73. doi:10.1016/j.jpain.2011.08.010
64. Chaparro LE, Wiffen PJ, Moore RA, Gilron I. Combination pharmacotherapy for the treatment of neuropathic pain in adults. Cochrane Database Syst Rev (2012) 7:CD008943. doi:10.1002/14651858.CD008943.pub2
65. Naylor MR, Naud S, Keefe FJ, Helzer JE. Therapeutic interactive voice response (TIVR) to reduce analgesic medication use for chronic pain management. J Pain (2010) 11:1410-9. doi:10.1016/j.jpain.2010.03.019
66. Moon H, Baek Y. Exploring variables affecting player's intrinsic motivation in educational games. The 17th International Conference on Computers in Education. Hong Kong: Asia-Pacific Society for Computers in Education (2009).
67. Cole SW, Yoo DJ, Knutson B. Interactivity and reward-related neural activation during a serious videogame. PLoS One (2012) 7:e33909. doi:10.1371/journal.pone.0033909
68. Katsyri J, Hari R, Ravaja N, Nummenmaa L. Just watching the game ain't enough: striatal fMRI reward responses to successes and failures in a video game during active and vicarious playing. Front Hum Neurosci (2013) 7:278. doi:10.3389/fnhum.2013.00278
69. Koepp MJ, Gunn RN, Lawrence AD, Cunningham VJ, Dagher A, Jones T, et al. Evidence for striatal dopamine release during a video game. Nature (1998) 393:266-8. doi:10.1038/30498
70. Gold BP, Frank MJ, Bogert B, Brattico E. Pleasurable music affects reinforcement learning according to the listener. Front Psychol (2013) 4:541. doi:10.3389/fpsyg.2013.00541
71. Salimpoor VN, Benovoy M, Larcher K, Dagher A, Zatorre RJ. Anatomically distinct dopamine release during anticipation and experience of peak emotion to music. Nat Neurosci (2011) 14:257-62. doi:10.1038/nn.2726
72. Salimpoor VN, van den Bosch I, Kovacevic N, McIntosh AR, Dagher A, Zatorre RJ. Interactions between the nucleus accumbens and auditory cortices predict music reward value. Science (2013) 340:216-9. doi:10.1126/science.1231059
73. Osuch EA, Bluhm RL, Williamson PC, Theberge J, Densmore M, Neufeld RW. Brain activation to favorite music in healthy controls and depressed patients. Neuroreport (2009) 20:1204-8. doi:10.1097/WNR.0b013e32832f4da3
74. Salamone JD, Correa M. The mysterious motivational functions of mesolimbic dopamine. Neuron (2012) 76:470-85. doi:10.1016/j.neuron.2012.10.021
75. Howe MW, Tierney PL, Sandberg SG, Phillips PE, Graybiel AM. Prolonged dopamine signalling in striatum signals proximity and value of distant rewards. Nature (2013) 500:575-9. doi:10.1038/nature12475
76. Han DH, Renshaw PF, Sim ME, Kim JI, Arenella LS, Lyoo IK. The effect of internet video game play on clinical and extrapyramidal symptoms in patients with schizophrenia. Schizophr Res (2008) 103:338-40. doi:10.1016/j.schres.2008.01.026
77. Pompeu JE, Arduini LA, Botelho AR, Fonseca MB, Pompeu SM, Torriani-Pasin C, et al. Feasibility, safety and outcomes of playing Kinect Adventures!™ for people with Parkinson's disease: a pilot study. Physiotherapy (2014) 100:162-8. doi:10.1016/j.physio.2013.10.003
78. Mehndiratta P, Sajatovic M. Treatments for patients with comorbid epilepsy and depression: a systematic literature review. Epilepsy Behav (2013) 28:36-40. doi:10.1016/j.yebeh.2013.03.029
79. Schmidt D, Sillanpaa M. Evidence-based review on the natural history of the epilepsies. Curr Opin Neurol (2012) 25:159-63. doi:10.1097/WCO.0b013e3283507e73
80. Faught E, Duh MS, Weiner JR, Guerin A, Cunnington MC. Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM study. Neurology (2008) 71:1572-8. doi:10.1212/01.wnl.0000319693.10338.b9
81. Ettinger AB, Manjunath R, Candrilli SD, Davis KL. Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy. Epilepsy Behav (2009) 14:324-9. doi:10.1016/j.yebeh.2008.10.021
82. Manjunath R, Davis KL, Candrilli SD, Ettinger AB. Association of antiepileptic drug nonadherence with risk of seizures in adults with epilepsy. Epilepsy Behav (2009) 14(2):372-8. doi:10.1016/j.yebeh.2008.12.006
83. Cardamone L, Salzberg MR, O'Brien TJ, Jones NC. Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder? Br J Pharmacol (2013) 168:1531-54. doi:10.1111/bph.12052
84. Lin LC, Lee WT, Wang CH, Chen HL, Wu HC, Tsai CL, et al. Mozart K.448 acts as a potential add-on therapy in children with refractory epilepsy. Epilepsy Behav (2011) 20:490-3. doi:10.1016/j.yebeh.2010.12.044
85. Bozzi Y, Borrelli E. The role of dopamine signaling in epileptogenesis. Front Cell Neurosci (2013) 7:157. doi:10.3389/fncel.2013.00157
86. Odano I, Varrone A, Savic I, Ciumas C, Karlsson P, Jucaite A, et al. Quantitative PET analyses of regional [11C]PE2I binding to the dopamine transporter - application to juvenile myoclonic epilepsy. Neuroimage (2012) 59:3582-93. doi:10.1016/j.neuroimage.2011.10.067
87. Rocha L, Alonso-Vanegas M, Villeda-Hernandez J, Mujica M, Cisneros-Franco JM, Lopez-Gomez M, et al. Dopamine abnormalities in the neocortex of patients with temporal lobe epilepsy. Neurobiol Dis (2012) 45:499-507. doi:10.1016/j.nbd.2011.09.006
88. Werhahn KJ, Landvogt C, Klimpe S, Buchholz HG, Yakushev I, Siessmeier T, et al. Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET study. Epilepsia (2006) 47:1392-6. doi:10.1111/j.1528-1167.2006.00561.x
89. Allendorfer JB, Heyse H, Mendoza L, Nelson EB, Eliassen JC, Storrs JM, et al. Physiologic and cortical response to acute psychosocial stress in left temporal lobe epilepsy - a pilot cross-sectional fMRI study. Epilepsy Behav (2014) 36C:115-23. doi:10.1016/j.yebeh.2014.05.003
90. Schmitt FC, Voges J, Heinze HJ, Zaehle T, Holtkamp M, Kowski AB. Safety and feasibility of nucleus accumbens stimulation in five patients with epilepsy. J Neurol (2014). doi:10.1007/s00415-014-7364-1
91. Raglio A, Farina E, Giovagnoli AR. Can music therapy alleviate psychological, cognitive, and behavioral impairment in epilepsy? Epilepsy Behav (2014) 31:7-8. doi:10.1016/j.yebeh.2013.10.008
92. Modi AC, Rausch JR, Glauser TA. Early pediatric antiepileptic drug nonadherence is related to lower long-term seizure freedom. Neurology (2014) 82:671-3. doi:10.1212/WNL.0000000000000147
93. Tavakoli F, Hoseini SE, Mokhtari M, Vahdati A, Razmi N, Vessal M. Role of music in morphine rewarding effects in mice using conditioned place preference method. Neuro Endocrinol Lett (2012) 33:709-12.
94. Lin LC, Juan CT, Chang HW, Chiang CT, Wei RC, Lee MW, et al. Mozart K.448 attenuates spontaneous absence seizure and related high-voltage rhythmic spike discharges in Long Evans rats. Epilepsy Res (2013) 104:234-40. doi:10.1016/j.eplepsyres.2012.11.005
95. Tasset I, Quero I, Garcia-Mayorgaz AD, del Rio MC, Tunez I, Montilla P. Changes caused by haloperidol are blocked by music in Wistar rat. J Physiol Biochem (2012) 68:175-9. doi:10.1007/s13105-011-0129-8
96. Lu Y, Liu M, Shi S, Jiang H, Yang L, Liu X, et al. Effects of stress in early life on immune functions in rats with asthma and the effects of music therapy. J Asthma (2010) 47:526-31. doi:10.3109/02770901003801964
97. Rauscher FH, Robinson KD, Jens JJ. Improved maze learning through early music exposure in rats. Neurol Res (1998) 20:427-32.
98. Rauscher FH, Shaw GL, Ky KN. Listening to Mozart enhances spatial-temporal reasoning: towards a neurophysiological basis. Neurosci Lett (1995) 185:44-7. doi:10.1016/0304-3940(94)11221-4
99. Aoun P, Jones T, Shaw GL, Bodner M. Long-term enhancement of maze learning in mice via a generalized Mozart effect. Neurol Res (2005) 27:791-6. doi:10.1179/016164105X63647
100. Ramos A, Lopez A, Rodrigez A, Meng T, Abrams S. The Legal Status of Video Games: Comparative Analysis in National Approaches. World Intellectual Property Organization (2013). p. 1-96. Available from: http://www.wipo.int/export/sites/www/copyright/en/activities/pdf/comparative_analysis_on_video_games.pdf
101. DeFulio A, Silverman K. The use of incentives to reinforce medication adherence. Prev Med (2012) 55(Suppl):S86-94. doi:10.1016/j.ypmed.2012.04.017
102. Brady TJ, Murphy L, Beauchesne D, Bhalakia A, Chervin D, Daniels B, et al. Sorting Through the Evidence for the Arthritis Self-Management Program and the Chronic Disease Self-management Program. Atlanta: Center for Disease Control and Prevention (2011). p. 1-24.
103. White HS, Loscher W. Searching for the ideal antiepileptogenic agent in experimental models: single treatment versus combinatorial treatment strategies. Neurotherapeutics (2014) 11:373-84. doi:10.1007/s13311-013-0250-1
104. Bucklen KW, Abbott BM. Promise and challenges with the use of mobile applications to support and improve patient care: an industry perspective. Clin Pharmacol Ther (2014) 95:469-71. doi:10.1038/clpt.2014.34
105. Robinson R. What's in a Game? Better Health Outcomes. PharmaVOICE (2014). Available from: http://www.pharmavoice.com/archives/article.esiml?id=2841
106. Harrison C. Patenting natural products just got harder. Nat Biotechnol (2014) 32:403-4. doi:10.1038/nbt0514-403a
107. Yetisen AK, Martinez-Hurtado JL, da Cruz Vasconcellos F, Simsekler MC, Akram MS, Lowe CR. The regulation of mobile medical applications. Lab Chip (2014) 14:833-40. doi:10.1039/c3lc51235e
108. Couto DS, Perez-Breva L, Saraiva P, Cooney CL. Lessons from innovation in drug-device combination products. Adv Drug Deliv Rev (2012) 64:69-77. doi:10.1016/j.addr.2011.10.008
109. Hupcey MA, Ekins S. Improving the drug selection and development process for combination devices. Drug Discov Today (2007) 12:844-52. doi:10.1016/j.drudis.2007.07.020
110. Food and Drug Administartion. Early Development Considerations for Innovative Combination Products, Guidance for Industry and FDA Staff (2006). Available from: http://www.fda.gov/regulatoryinformation/guidances/ucm126050.htm
111. Food and Drug Administration. Office of Combination Products, Performance Report FY 2012 (2012). Available from: http://www.fda.gov/AboutFDA/ReportsManualsForms/Reports/PerformanceReports/CombinationProducts/ucm365878.htm